Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
More transparency, evidence needed for accelerated nods: ICER
The FDA should strengthen the evidence required for accelerated drug approvals and increase transparency surrounding those decisions, ICER says.
Kevin Dunleavy
Apr 17, 2026 11:22am
Lilly answers FDA's call for more Foundayo safety information
Apr 16, 2026 9:43am
United's Tyvaso backs up case for IPF expansion with ph. 3 win
Mar 30, 2026 3:06pm
Bayer tees up Kerendia for major CKD label expansion
Mar 16, 2026 9:46am
Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus
Feb 19, 2026 10:40am
Novartis jockeys for Rhapsido FDA nod in unclaimed hives subtype
Feb 18, 2026 9:49am
